Volume 11, Issue 2 (March & April - Special Issue on COVID-19 2020)
BCN 2020, 11(2): 155-162 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Baldacchino A, Radfar S R, De Jong C, Rafei P, Yunesian M, Gerra G, et al et al . COVID-19 and Substance Use Disorder: Study Protocol for the International Society of Addiction Medicine Practice and Policy Interest Group Global Survey. BCN 2020; 11 (2) :155-162
URL: http://bcn.iums.ac.ir/article-1-1821-en.html
URL: http://bcn.iums.ac.ir/article-1-1821-en.html
Alexander Baldacchino1 
, Seyed Ramin Radfar2 , Cornelis De Jong3 , Parnian Rafei4 , Masud Yunesian5 , Gilberto Gerra6 , Kathleen Brady7 , Mohsen Ebrahimi8 , Mehrnoosh Vahidi * 9, Arash Khojasteh Zonoozi10 , Hossein Mohaddes Ardabili11 , Anja Busse12 , Elizabeth Saenz12 , Giovanna Campello12 , Kamran Niaz13 , Hamed Ekhtiari14 , Ali Farhoudian15
, Seyed Ramin Radfar2 , Cornelis De Jong3 , Parnian Rafei4 , Masud Yunesian5 , Gilberto Gerra6 , Kathleen Brady7 , Mohsen Ebrahimi8 , Mehrnoosh Vahidi * 9, Arash Khojasteh Zonoozi10 , Hossein Mohaddes Ardabili11 , Anja Busse12 , Elizabeth Saenz12 , Giovanna Campello12 , Kamran Niaz13 , Hamed Ekhtiari14 , Ali Farhoudian15
1- Division of Population and Behavioral Sciences, St Andrews University Medical School, University of St Andrews, UK.
2- Integrated Substance Abuse Programs, University of California, Los Angeles, CA, USA.
3- Behavioral Science Institute, Radboud University, the Netherlands.
4- Faculty of Psychology and Education, University of Tehran, Tehran, Iran.
5- Department of Research methodology and Data Analysis, Institute for Environmental Research, Tehran University of Medical sciences, Tehran, Iran.
6- Drug Prevention and Health Branch, Division for Operations, United Nations Office on Drugs and Crime, Vienna, Austria.
7- Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, USA.
8- Department of Semiconductors, Materials and Energy Research Center (MERC), Tehran, Iran.
9- Department of Psychiatry, Tehran University of Medical Sciences, Tehran, Iran.
10- Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
11- Psychiatry and Behavioral Sciences Research Center, Ibn-e-Sina Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
12- Prevention, Treatment and Rehabilitation Section; Drug Prevention and Health Branch, Division for Operations, United Nations Office on Drugs and Crime, Vienna, Austria.
13- Research and Trend Analysis Branch, Division for Policy Affairs, United Nations Office on Drugs and Crime, Vienna, Austria.
14- Laureate Institute for Brain Research, Tulsa, Oklahoma, USA.
15- Department of Psychiatry, Tehran University of Medical Sciences, Tehran, Iran; Substance Abuse and Dependence Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
2- Integrated Substance Abuse Programs, University of California, Los Angeles, CA, USA.
3- Behavioral Science Institute, Radboud University, the Netherlands.
4- Faculty of Psychology and Education, University of Tehran, Tehran, Iran.
5- Department of Research methodology and Data Analysis, Institute for Environmental Research, Tehran University of Medical sciences, Tehran, Iran.
6- Drug Prevention and Health Branch, Division for Operations, United Nations Office on Drugs and Crime, Vienna, Austria.
7- Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, USA.
8- Department of Semiconductors, Materials and Energy Research Center (MERC), Tehran, Iran.
9- Department of Psychiatry, Tehran University of Medical Sciences, Tehran, Iran.
10- Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
11- Psychiatry and Behavioral Sciences Research Center, Ibn-e-Sina Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
12- Prevention, Treatment and Rehabilitation Section; Drug Prevention and Health Branch, Division for Operations, United Nations Office on Drugs and Crime, Vienna, Austria.
13- Research and Trend Analysis Branch, Division for Policy Affairs, United Nations Office on Drugs and Crime, Vienna, Austria.
14- Laureate Institute for Brain Research, Tulsa, Oklahoma, USA.
15- Department of Psychiatry, Tehran University of Medical Sciences, Tehran, Iran; Substance Abuse and Dependence Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
Abstract:
Introduction: As one of the major health problems in the present century, the COVID-19 pandemic affected all parts of the global communities and the health of substance users are potentially at a greater risk of harm. This global study has been designed and conducted by the International Society of Addiction Medicine Practice and Policy Interest Group (ISAM-PPIG) to understand better the health related issues of people with Substance Use Disorders (SUD) as well as responses of the relevant health care systems during the pandemic.
Methods: This is a cross-sectional study using convenient sampling. The data gathering was carried out with two follow-up stages each two months apart through an online conducted survey prepared using Google platform. The survey started by emergence of COVID-19 as a pandemic in March 2020 and respondents were followed till September 2020 when most of the initial lockdowns by most countries are supposed to be reopened.
Ethics and Dissemination: The study was approved by the ethics committee of University of Social Welfare and Rehabilitation Sciences, Tehran, Iran. The results will be published in relevant peer reviewing journals and communicated with different international stakeholders.
Methods: This is a cross-sectional study using convenient sampling. The data gathering was carried out with two follow-up stages each two months apart through an online conducted survey prepared using Google platform. The survey started by emergence of COVID-19 as a pandemic in March 2020 and respondents were followed till September 2020 when most of the initial lockdowns by most countries are supposed to be reopened.
Ethics and Dissemination: The study was approved by the ethics committee of University of Social Welfare and Rehabilitation Sciences, Tehran, Iran. The results will be published in relevant peer reviewing journals and communicated with different international stakeholders.
Keywords: COVID-19, SARS-CoV-2, Pandemics, Substance-related disorders, Drug addiction, Public health, Health policy, Disaster medicine, Opiate substitution treatment, Telemedicine, Mental health Services, Health surveys, Country response
Type of Study: Original |
Subject:
Clinical Neuroscience
Received: 2020/06/13 | Accepted: 2020/06/13 | Published: 2020/06/15
Received: 2020/06/13 | Accepted: 2020/06/13 | Published: 2020/06/15
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Copyright © The Author(s);
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC-By-NC), which permits use, distribution, and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Contact Information
